These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38528704)

  • 1. The IMPOWR Network Divided or Single Exposure Study (DOSE) Protocol: A Randomized Controlled Comparison of Once Versus Split Dosing of Methadone for the Treatment of Comorbid Chronic Pain and Opioid Use Disorder.
    McKendrick G; Davis W; Sklar M; Brown N; Pattillo E; Finan PH; Antoine D; Walters V; Dunn KE
    Subst Use Addctn J; 2024 Mar; ():29767342241239167. PubMed ID: 38528704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.
    Ellerbroek H; van den Heuvel SAS; Dahan A; Timmerman H; Kramers C; Schellekens AFA
    Addict Sci Clin Pract; 2022 Sep; 17(1):47. PubMed ID: 36057608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of opioid use disorder treatment outcomes in patients receiving split daily versus once daily dosing of buprenorphine-naloxone.
    Borris JB; Dowd-Green C; Bowman LA; Nesbit SA; Fingerhood M; Stewart RW
    J Subst Use Addict Treat; 2024 Jan; 156():209209. PubMed ID: 37939905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic.
    Dunn KE; Brooner RK; Stoller KB
    J Subst Abuse Treat; 2021 Feb; 121():108197. PubMed ID: 33357606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial.
    Ware OD; Sweeney MM; Cunningham C; Umbricht A; Stitzer M; Dunn KE
    JAMA Netw Open; 2023 Mar; 6(3):e232278. PubMed ID: 36920397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral Treatment.
    MacLean RR; Ankawi B; Driscoll MA; Gordon MA; Frankforter TL; Nich C; Szollosy SK; Loya JM; Brito L; Ribeiro MIP; Edmond SN; Becker WC; Martino S; Sofuoglu M; Heapy AA
    JMIR Res Protoc; 2024 Mar; 13():e54342. PubMed ID: 38506917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment.
    Belcher AM; Cole TO; Greenblatt AD; Hoag SW; Epstein DH; Wagner M; Billing AS; Massey E; Hamilton KR; Kozak ZK; Welsh CJ; Weintraub E; Wickwire EM; Wish ED; Kaptchuk TJ; Colloca L
    BMJ Open; 2019 Jun; 9(6):e026604. PubMed ID: 31230007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperbaric Oxygen Therapy for Pain, Opioid Withdrawal, and Related Symptoms: A Pilot Randomized Controlled Trial.
    Wilson M; Bindler RJ; Stanek K; Layton ME; Quock RM
    Pain Manag Nurs; 2022 Oct; 23(5):616-624. PubMed ID: 35393218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Conditioned Open-label Placebo With Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial.
    Belcher AM; Cole TO; Massey E; Billing AS; Wagner M; Wooten W; Epstein DH; Hoag SW; Wickwire EM; Greenblatt AD; Colloca L; Rotrosen J; Magder L; Weintraub E; Wish ED; Kaptchuk TJ
    JAMA Netw Open; 2023 Apr; 6(4):e237099. PubMed ID: 37043203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
    Scott TM; Arnsten J; Olsen JP; Arias F; Cunningham CO; Rivera Mindt M
    Addict Sci Clin Pract; 2021 Oct; 16(1):64. PubMed ID: 34689841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a methadone-initiated memory reconsolidation updating procedure in opioid use disorder: A translational study.
    Yue JL; Yuan K; Bao YP; Meng SQ; Shi L; Fang Q; Guo XJ; Cao L; Sun YK; Lu TS; Zeng N; Yan W; Han Y; Sun J; Shi J; Kosten TR; Xue YX; Wu P; Lu L
    EBioMedicine; 2022 Nov; 85():104283. PubMed ID: 36182773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta-9-tetrahydrocannabinol modulates pain sensitivity among persons receiving opioid agonist therapy for opioid use disorder: A within-subject, randomized, placebo-controlled laboratory study.
    De Aquino JP; Meyerovich J; Xie CZ; Ranganathan M; Compton P; Pittman B; Rogan M; Sofuoglu M
    Addict Biol; 2023 Sep; 28(9):e13317. PubMed ID: 37644897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.
    De Aquino JP; Parida S; Avila-Quintero VJ; Flores J; Compton P; Hickey T; Gómez O; Sofuoglu M
    Drug Alcohol Depend; 2021 Nov; 228():109097. PubMed ID: 34601272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.
    Benville JR; Compton P; Giordano NA; Cheatle MD
    Drug Alcohol Depend; 2021 Apr; 221():108619. PubMed ID: 33667781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone.
    Webster LR; Israel RJ
    J Pain Res; 2018; 11():2509-2516. PubMed ID: 30425563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.